ADAPY
Adaptimmune Therapeutics Plc - ADR

9,329
Mkt Cap
$954,200.00
Volume
64,608.00
52W High
$0.3578
52W Low
$0.0001
PE Ratio
-0.01
ADAPY Fundamentals
Price
$0.0036
Prev Close
$0.01
Open
$0.0035
50D MA
$0.014
Beta
1.74
Avg. Volume
363,679.62
P/B
-0.01
Loading...
Loading...

About

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Adaptimmune Therapeutics Plc - ADR?
What is the 52-week high for Adaptimmune Therapeutics Plc - ADR?
What is the 52-week low for Adaptimmune Therapeutics Plc - ADR?
What is Adaptimmune Therapeutics Plc - ADR stock price today?
What was Adaptimmune Therapeutics Plc - ADR stock price yesterday?
What is the PE ratio of Adaptimmune Therapeutics Plc - ADR?
What is the Price-to-Book ratio of Adaptimmune Therapeutics Plc - ADR?
What is the 50-day moving average of Adaptimmune Therapeutics Plc - ADR?

Latest ADAPY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.